1 Dermatology department, AP-HP, Henri Mondor Hospital, 51, avenue du Maréchal de Lattre de Tassigny, 94000 Créteil, France.
2 Dermatology department, AP-HP, Henri Mondor Hospital, 51, avenue du Maréchal de Lattre de Tassigny, 94000 Créteil, France; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions-TOXIBUL, 94000 Créteil, France. Electronic address: [email protected].
3 Regional Pharmacovigilance Center, AP-HP, Pitié-Salpêtrière Hospital, 75013 Paris, France; Department of Clinical Immunology, Antoine-Béclère Hospital, 92140 Clamart, France.
4 Dermatology department, AP-HP, Henri Mondor Hospital, 51, avenue du Maréchal de Lattre de Tassigny, 94000 Créteil, France; Université Paris Est Créteil Val de Marne, UPEC, 94000 Créteil, France.
5 Université Paris Est Créteil Val de Marne, UPEC, 94000 Créteil, France; Pathology Department, AP-HP, Henri Mondor Hospital, 94000 Créteil, France.
6 Emergency Department, AP-HP, Henri Mondor Hospital, 94000 Créteil, France.
7 Department of Clinical Immunology, Antoine-Béclère Hospital, 92140 Clamart, France.
8 Dermatology department, AP-HP, Henri Mondor Hospital, 51, avenue du Maréchal de Lattre de Tassigny, 94000 Créteil, France; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions-TOXIBUL, 94000 Créteil, France; Université Paris Est Créteil Val de Marne, UPEC, 94000 Créteil, France.
9 Pharmacovigilance Center, AP-HP, Henri Mondor Hospital, 94000 Créteil, France.
10 Dermatology department, AP-HP, Henri Mondor Hospital, 51, avenue du Maréchal de Lattre de Tassigny, 94000 Créteil, France; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions-TOXIBUL, 94000 Créteil, France; EA 7379 EpidermE, UPEC, 94000 Créteil, France.